YOLFTbeta
DRI Healthcare Trust

DRI Healthcare Trust

DHT-UN · TO · Healthcare / Drug Manufacturers - Specialty & Generic

19.11CAD-0.36 (-1.85%)

Price History

Full chart

Market Stats

Previous Close19.47
Open19.57
Day Range19.00 – 19.58
52-Week Range13.61 – 19.58
Volume23.81K
Market Cap1.04B
P/E (TTM)0.00
Forward P/E23.20
EPS-1.14
Dividend Yield3.27%
Beta0.67
50-Day Avg17.69
200-Day Avg17.05

About

DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Zaheed Mawani
  • Employees32
  • Headquarters100 King Street West, Toronto, ON, Canada, M5X 1B1, Canada
  • Websitehttps://www.dricapital.com

Leadership

  • Mr. Zaheed MawaniChief Financial Officer
  • Mr. Navin Cyriac JacobExecutive VP, Head of Investments & Research - DRI Capital Inc.
  • Mr. Babak FarahmandExecutive Vice President of Asset Operations & Analytics - DRI Capital Inc.
  • Mr. Emmanuel CoeytauxExecutive Vice President of Strategy
  • Mr. Lee SchechterSenior VP of Research & Investments

Financials

Income Statement

Currency: USD2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue-73.33M79.87M117.44M138.55M195.17M
Growth (%)--+8.92%+47.04%+17.97%+40.87%
Cost of Revenue---137.80M71.94M216.68M
Gross Profit-73.33M79.87M-20.36M66.60M-21.51M
Gross Margin-100.00%100.00%-17.33%48.07%-11.02%
Operating Expense-51.77M68.27M-38.96M-92.36M-82.81M
Operating Income-2.17K21.56M11.60M18.60M158.96M61.30M
Operating Margin-29.40%14.52%15.84%114.73%31.41%
EBITDA-66.06M76.77M107.52M-4.94M92.25M
EBITDA Margin-90.08%96.12%91.55%-3.56%47.27%
Net Income-2.17K21.56M11.60M91.50M-3.36M-51.35M
Net Income Margin-29.40%14.52%77.91%-2.43%-26.31%
Interest Expense02.24M6.63M26.50M35.44M40.39M
Interest Expense % of Total Revenue-3.05%8.30%22.57%25.58%20.69%

Balance Sheet

Currency: USD2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets10436.69M633.42M833.16M984.87M941.10M
Total Liabilities36257.71M261.08M273.46M457.34M503.32M
Total Equity-352378.99M372.34M561.50M527.53M437.78M
Cash1061.71M36.69M62.84M36.50M42.35M
Total Debt-43.92M244.99M145.48M432.12M482.06M
Net Debt-10-17.79M208.30M-62.84M395.61M439.71M

Cash Flow

Currency: USD2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow91.86M91.86M77.47M76.38M155.41M78.11M
Investing Cash Flow-372.33M-372.33M-273.67M-128.81M-293.31M-81.64M
Financing Cash Flow60342.18M171.17M78.57M111.56M9.56M
Capital Expenditure0324.33M274.50M391.19M285.25M89.53M
Free Cash Flow--232.46M-197.03M-313.90M-129.84M-11.42M
Dividends Paid3.68M3.68M20.23M32.68M33.60M21.48M
FCF to OCF--253.05%-254.34%-410.96%-83.54%-14.62%
Dividend Paid to FCF--1.58%-10.26%-10.41%-25.88%-188.07%

Earnings

Report DateMay 10, 2021Aug 5, 2021Nov 8, 2021Mar 7, 2022May 10, 2022Aug 3, 2022Nov 7, 2022Mar 1, 2023May 11, 2023Aug 14, 2023Nov 13, 2023Feb 28, 2024May 6, 2024Aug 6, 2024Nov 6, 2024Mar 3, 2025May 12, 2025Aug 13, 2025Nov 5, 2025Mar 3, 2026May 14, 2026Aug 7, 2026Nov 5, 2026
EPS Estimate0.320.630.420.480.280.400.420.500.420.410.540.450.480.450.440.540.510.480.550.520.550.600.77
EPS Actual0.540.460.480.410.490.430.570.390.490.400.461.020.470.490.450.760.430.510.550.780.680.56-
Surprise68.75%-26.98%14.29%-14.58%75.00%7.50%35.71%-22.00%16.67%-2.44%-14.81%126.67%-2.08%8.89%2.27%40.74%-15.69%6.25%0.00%50.00%23.64%-6.67%-
TimingPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap1.04B
Enterprise Value1.40B
Trailing P/E0.00
Forward P/E23.20
Price / Sales5.16
Price / Book1.63
EPS-1.14
Book Value11.27
Revenue (TTM)200.72M
Gross Profit (TTM)200.72M
EBITDA172.01M
Profit Margin-21.95%
Operating Margin34.72%
Return on Equity-9.39%
Return on Assets4.43%
Shares Outstanding0
Shares Float38.57M
Beta0.67
Dividend Yield3.27%
Dividend Rate0.60
Payout Ratio23.42%

Dividends

20262×
0.16Jun 30, 20260.15Mar 31, 2026
20254×
0.14Dec 31, 20250.14Sep 29, 20250.14Jun 30, 20250.14Mar 31, 2025
20244×
0.12Dec 31, 20240.11Sep 27, 20240.12Jun 28, 20240.12Mar 27, 2024
20234×
0.45Dec 28, 20230.10Sep 28, 20230.80Jun 29, 20230.10Mar 30, 2023
20224×
0.10Dec 29, 20220.10Sep 28, 20220.10Jun 29, 20220.09Mar 30, 2022
20214×
0.38Dec 30, 20210.05Sep 28, 20210.05Jun 29, 20210.02Mar 30, 2021

Stock Splits

  • Dec 31, 2024997:1000